Skip to content

Questionnaire Survey of Patients Using Accu-chek mobile

Questionnaire Survey of Patients Using Accu-chek mobile - QSACM

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012088
Enrollment
50
Registered
2013-10-23
Start date
2013-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus

Interventions

SMBG machine and lancet device currently prescribed / Accu-chek mobile

Sponsors

Saitama Medical Center, Saitama Medical University Roche Diagnostics Japan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with diabetes mellitus and receiving insulin or GLP-1 receptor agonist treatment under SMBG (self-monitoring of blood glucose)

Exclusion criteria

Exclusion criteria: patients who don't agree to this study

Design outcomes

Primary

MeasureTime frame
1) Evaluation on manipulation of SMBG devices (needle and monitor), 2) Impact on psychological and physical stress, comparing SMBG devices currently in use

Secondary

MeasureTime frame
1) Function of SMBG devices that would be found from the point of medical providers 2) Discrepancy of needs of patients and medical providers 3) Evaluation of Accu-chek mobile by medical providers 4) Possibility of lowering efforts by medical providers

Countries

Japan

Contacts

Public ContactMasafumi Matsuda

Saitama Medical Center, Saitama Medical University Depertment of Endocrinology and Diaebtes

matsudam-ind@umin.ac.jp+81-49-228-3564

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026